162 related articles for article (PubMed ID: 24011881)
1. Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration.
Starkman MN
Endocrinol Metab Clin North Am; 2013 Sep; 42(3):477-88. PubMed ID: 24011881
[TBL] [Abstract][Full Text] [Related]
2. Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation.
Bouzas EA; Mastorakos G; Friedman TC; Scott MH; Chrousos GP; Kaiser-Kupfer MI
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3497-500. PubMed ID: 8258505
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids and cognition.
Belanoff JK; Gross K; Yager A; Schatzberg AF
J Psychiatr Res; 2001; 35(3):127-45. PubMed ID: 11461709
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids. Mood, memory, and mechanisms.
Wolkowitz OM; Burke H; Epel ES; Reus VI
Ann N Y Acad Sci; 2009 Oct; 1179():19-40. PubMed ID: 19906230
[TBL] [Abstract][Full Text] [Related]
5. Phenomenology and family history of affective disorder in Cushing's disease.
Starkman MN
Am J Psychiatry; 1988 Mar; 145(3):390-1. PubMed ID: 3344870
[No Abstract] [Full Text] [Related]
6. [Glucocorticoid-induced osteoporosis: recent findings].
Angeli A; Osella G; Reimondo G; Terzolo M
Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891
[TBL] [Abstract][Full Text] [Related]
7. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome.
Merke DP; Giedd JN; Keil MF; Mehlinger SL; Wiggs EA; Holzer S; Rawson E; Vaituzis AC; Stratakis CA; Chrousos GP
J Clin Endocrinol Metab; 2005 May; 90(5):2531-6. PubMed ID: 15741254
[TBL] [Abstract][Full Text] [Related]
8. Neuroscientific basis of corticosteroid-induced changes in human cognitive and emotional processing: implications for affective illness.
Young KD; Preskorn SH
J Psychiatr Pract; 2013 Jul; 19(4):309-15. PubMed ID: 23852106
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric disorders in Cushing's syndrome.
Pereira AM; Tiemensma J; Romijn JA
Neuroendocrinology; 2010; 92 Suppl 1():65-70. PubMed ID: 20829621
[TBL] [Abstract][Full Text] [Related]
10. Cushing's syndrome caused by short-term topical glucocorticoid use for erythrodermic psoriasis and development of adrenal insufficiency after glucocorticoid withdrawal.
Durmazlar SP; Oktay B; Eren C; Eskioglu F
Eur J Dermatol; 2009; 19(2):169-70. PubMed ID: 19106046
[No Abstract] [Full Text] [Related]
11. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited.
Dubovsky AN; Arvikar S; Stern TA; Axelrod L
Psychosomatics; 2012; 53(2):103-15. PubMed ID: 22424158
[TBL] [Abstract][Full Text] [Related]
12. Exogenous Cushing's syndrome and glucocorticoid withdrawal.
Hopkins RL; Leinung MC
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):371-84, ix. PubMed ID: 15850848
[TBL] [Abstract][Full Text] [Related]
13. A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess.
León-Carrión J; Atutxa AM; Mangas MA; Soto-Moreno A; Pumar A; Leon-Justel A; Martín-Rodriguez JF; Venegas E; Domínguez-Morales MR; Leal-Cerro A
Clin Endocrinol (Oxf); 2009 Feb; 70(2):192-200. PubMed ID: 18702680
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome.
Paes T; Feelders RA; Hofland LJ
J Clin Endocrinol Metab; 2024 May; 109(6):e1424-e1433. PubMed ID: 38517306
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome.
Zhang CD; Ioachimescu AG
Front Endocrinol (Lausanne); 2024; 15():1353543. PubMed ID: 38681763
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance, hypercortisolism, polycystic ovarian syndrome, and depression--nonrandom associations?
Castillo-Quan JI
Fertil Steril; 2008 Apr; 89(4):1029-30; author reply 1030. PubMed ID: 18325512
[No Abstract] [Full Text] [Related]
17. Neuropsychiatric manifestations of patients with Cushing's syndrome. Relationship to cortisol and adrenocorticotropic hormone levels.
Starkman MN; Schteingart DE
Arch Intern Med; 1981 Feb; 141(2):215-9. PubMed ID: 6257194
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy.
Hardy RS; Zhou H; Seibel MJ; Cooper MS
Endocr Rev; 2018 Oct; 39(5):519-548. PubMed ID: 29905835
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.
Sapolsky RM
Arch Gen Psychiatry; 2000 Oct; 57(10):925-35. PubMed ID: 11015810
[TBL] [Abstract][Full Text] [Related]
20. Stress and glucocorticoid.
Yehuda R
Science; 1997 Mar; 275(5306):1662-3. PubMed ID: 9072828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
